Alkem Laboratories Limited (BOM:539523)
5,168.65
+23.65 (0.46%)
At close: Nov 20, 2026
Alkem Laboratories Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Alkem Laboratories stock has a consensus rating of "Buy" and an average price target of ₹5,983. The average 1-year stock price forecast is 15.75% higher than the current stock price, while the lowest is ₹4,589 (-11.21%) and the highest is ₹6,800 (+31.56%).
Price Target: ₹5,983 (+15.75%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Alkem Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 7 | 8 | 8 |
| Buy | 6 | 6 | 6 | 6 | 6 | 5 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 4 | 4 | 4 | 3 | 2 | 2 |
| Total | 20 | 20 | 20 | 20 | 20 | 20 |
Financial Forecast
Revenue This Year
167.33B
from 147.12B
Increased by 13.74%
Revenue Next Year
185.97B
from 167.33B
Increased by 11.13%
EPS This Year
185.59
from 204.53
Decreased by -9.26%
EPS Next Year
220.48
from 185.59
Increased by 18.80%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.